US$ 25.30
glp-1 drugs alzheimer's Older drug may help protect brains of patients In New Dementia Trials, Ozempic's
Description
doi: 10.1016/j.cmet.2018.03.001 20 KheraRMuradMHChandarAKDulaiPSWangZProkopLJet al

Editors note: The Spanish translation of this article was generated using artificial intelligence and may contain inaccuracies

These medications have a low risk of causing low blood sugar when used alone but may increase this risk when combined with insulin or sulfonylureas

While weight loss might lead to reduced health care costs (estimates suggest a reduction of around $250 billion), the current prices of the medications mean that the math doesnt quite add up for insurance companies

AM: I love that

Moreover, risk reductions were seen across all components of MACE, namely cardiovascular death, non-fatal heart attack and non-fatal stroke
